Remedium Lifecare [REMLIFE] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Remedium Lifecare Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Remedium Lifecare Ltd. wins in 5 metrics, Gujarat Themis Biosyn Ltd. wins in 14 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Remedium Lifecare Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 6.54 73.73 Remedium Lifecare Ltd.
Price-to-Book Ratio 0.71 13.36 Remedium Lifecare Ltd.
Debt-to-Equity Ratio 1,033.81 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 0.03 -17.55 Remedium Lifecare Ltd.
EV/EBITDA 206.57 52.76 Gujarat Themis Biosyn Ltd.
Profit Margin (TTM) 2.33% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 6.64% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 6.64% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 16.22% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 0.19% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-11.44B $-251.22M Gujarat Themis Biosyn Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -78.03% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 0.14 22.23 Remedium Lifecare Ltd.
Enterprise Value $11.62B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 2.21 22.65 Remedium Lifecare Ltd.
Gross Profit Margin (TTM) 9.53% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $8 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $0.13 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 1.04 -0.17 Gujarat Themis Biosyn Ltd.

Remedium Lifecare Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

REMLIFE
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare Ltd.-2.78%-5.41%-20.45%-30.00%-65.35%-53.33%
Gujarat Themis Biosyn Ltd.0.38%2.15%10.93%43.75%6.59%-6.25%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare Ltd.-78.03%-97.95%-55.81%245.45%245.45%245.45%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Remedium Lifecare Ltd. vs Gujarat Themis Biosyn Ltd.

MetricREMLIFEGUJTHEM
Market Information
Market Cap i₹308.70M₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,880,48979,452
90 Day Avg. Volume i13,121,813106,446
Last Close₹0.35₹413.20
52 Week Range₹0.32 - ₹1.80₹225.05 - ₹479.00
% from 52W High-80.56%-13.74%
All-Time High₹4,547.80 (Jul 03, 2023)₹479.00 (Oct 27, 2025)
% from All-Time High-99.99%-13.74%
Growth Metrics
Quarterly Revenue Growth3.43%0.10%
Quarterly Earnings Growth3.86%-0.04%
Financial Health
Profit Margin (TTM) i0.02%0.30%
Operating Margin (TTM) i0.07%0.40%
Return on Equity (TTM) i0.16%0.20%
Debt to Equity (MRQ) i1,033.8127.04
Cash & Liquidity
Book Value per Share (MRQ)₹1.19₹24.29
Cash per Share (MRQ)₹0.02₹0.92
Operating Cash Flow (TTM) i₹-9,983,884,288₹970.68M
Levered Free Cash Flow (TTM) i₹-9,656,687,616₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Remedium Lifecare Ltd. vs Gujarat Themis Biosyn Ltd.

MetricREMLIFE (Mar 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i6.5473.73
Forward P/E iN/AN/A
PEG Ratio i0.03-17.55
Price to Sales (TTM) i0.1422.23
Price to Book (MRQ) i0.7113.36
Market Capitalization
Market Capitalization i₹308.70M₹35.41B
Enterprise Value i₹11.62B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i2.2122.65
Enterprise to EBITDA i206.5752.76
Risk & Other Metrics
Beta i1.04-0.17
Book Value per Share (MRQ) i₹1.19₹24.29

Financial Statements Comparison: Remedium Lifecare Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREMLIFE (2025)GUJTHEM (2025)
Revenue/Sales i4.05B1.51B
Cost of Goods Sold i3.98B318.78M
COGS % of Revenue i98.2%21.1%
Gross Profit i71.16M1.19B
Gross Margin i1.8%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i12.30M642.49M
Operating Margin i0.3%42.6%
EBITDA i120.41M713.04M
EBITDA Margin i3.0%47.3%
Pre-Tax Income i43.84M655.38M
Pre-Tax Income % of Revenue i1.1%43.5%
Income Tax i22.55M167.66M
Income Tax % of Revenue i0.6%11.1%
Net Income (Profit) i21.29M487.72M
Profit Margin i0.5%32.3%

Balance Sheet & Liquidity Metrics

MetricREMLIFE (2025)GUJTHEM (2025)
Cash & Equivalents i2.82M116.94M
Total Current Assets i17.20B519.73M
Total Current Assets % of Revenue i424.5%34.5%
Total Current Liabilities i16.76B205.60M
Total Current Liabilities % of Revenue i413.7%13.6%
Long-Term Debt i0296.36M
Long-Term Debt % of Revenue i0.0%19.7%
Total Shareholders Equity i438.91M2.48B
Retained Earnings i35.71M2.37B
Retained Earnings % of Revenue i0.9%157.4%
Property, Plant & Equipment i83,000411.30M

Cash Flow Statement Comparison

MetricREMLIFE (2025)GUJTHEM (2025)
Operating Cash Flow i-16.38B970.68M
Operating Cash Flow % of Revenue i-404.2%64.4%
Capital Expenditures iN/A-1.16B
Free Cash Flow i-11.44B-251.22M
FCF Margin i-282.4%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFEGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i881.99M108.97M
Float Shares i382.00M29.52M
% Held by Insiders i15.76%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i84.24%26.84%

Dividend Analysis & Yield Comparison: Remedium Lifecare Ltd. vs Gujarat Themis Biosyn Ltd.

MetricREMLIFEGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025